NYSE:JNJ - Johnson & Johnson Stock Price, News, & Analysis

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

Johnson & Johnson announced a quarterly dividend on Wednesday, January 2nd. Stockholders of record on Tuesday, February 26th will be paid a dividend of $0.90 per share on Tuesday, March 12th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 2.80%. The ex-dividend date is Monday, February 25th. View Johnson & Johnson's Dividend History.

Johnson & Johnson declared that its board has initiated a stock repurchase program on Monday, December 17th 2018, which permits the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase up to 1.5% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board believes its stock is undervalued.

Johnson & Johnson (NYSE:JNJ) issued its quarterly earnings results on Tuesday, January, 22nd. The company reported $1.97 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.95 by $0.02. The company had revenue of $20.39 billion for the quarter, compared to analysts' expectations of $20.27 billion. Johnson & Johnson had a return on equity of 34.62% and a net margin of 1.89%. The company's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.74 earnings per share. View Johnson & Johnson's Earnings History.

Johnson & Johnson is scheduled to release their next quarterly earnings announcement on Tuesday, April 16th 2019. View Earnings Estimates for Johnson & Johnson.

Johnson & Johnson issued an update on its FY19 earnings guidance on Tuesday, January, 22nd. The company provided earnings per share (EPS) guidance of $8.50-8.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.60. The company issued revenue guidance of $80.4-81.2 billion, compared to the consensus revenue estimate of $82.74 billion.Johnson & Johnson also updated its FY 2019 guidance to $8.50-8.65 EPS.

13 Wall Street analysts have issued 12-month price objectives for Johnson & Johnson's stock. Their forecasts range from $110.00 to $160.00. On average, they expect Johnson & Johnson's stock price to reach $139.5455 in the next twelve months. This suggests a possible upside of 8.7% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 1 sell rating, 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Johnson & Johnson.

News stories about JNJ stock have been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Johnson & Johnson earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the stock's share price in the near term.

Johnson & Johnson saw a decline in short interest during the month of December. As of December 31st, there was short interest totalling 15,719,662 shares, a decline of 19.9% from the December 14th total of 19,633,883 shares. Based on an average trading volume of 15,979,892 shares, the short-interest ratio is presently 1.0 days. Approximately 0.6% of the shares of the company are sold short. View Johnson & Johnson's Current Options Chain.

Some companies that are related to Johnson & Johnson include Pfizer (PFE), Roche Holdings AG Basel (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), AbbVie (ABBV), Abbott Laboratories (ABT), Eli Lilly And Co (LLY), Novo Nordisk A/S (NVO), Sanofi (SNY), GlaxoSmithKline (GSK), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Bayer (BAYRY), Celgene (CELG) and Shire (SHPG).

Johnson & Johnson's stock is owned by many different of institutional and retail investors. Top institutional shareholders include DNB Asset Management AS (0.06%), Strs Ohio (0.06%), Hexavest Inc. (0.06%), Gateway Investment Advisers LLC (0.05%), Confluence Investment Management LLC (0.04%) and Nisa Investment Advisors LLC (0.04%). Company insiders that own Johnson & Johnson stock include Alex Gorsky, Charles Prince, Dominic J Caruso, Joaquin Duato, Michael E Sneed, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta. View Institutional Ownership Trends for Johnson & Johnson.

JNJ stock was sold by a variety of institutional investors in the last quarter, including Gulf International Bank UK Ltd, Atalanta Sosnoff Capital LLC, Sit Investment Associates Inc., USS Investment Management Ltd, Highland Capital Management LLC, Hexavest Inc., Howland Capital Management LLC and Moreno Evelyn V. Company insiders that have sold Johnson & Johnson company stock in the last year include Alex Gorsky, Joaquin Duato, Michael E Sneed, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta. View Insider Buying and Selling for Johnson & Johnson.

JNJ stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., KAMES CAPITAL plc, DNB Asset Management AS, Ferguson Wellman Capital Management Inc., Weather Gauge Advisory LLC, QCI Asset Management Inc. NY, Centre Asset Management LLC and Nisa Investment Advisors LLC. View Insider Buying and Selling for Johnson & Johnson.

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of JNJ stock can currently be purchased for approximately $128.43.

Johnson & Johnson has a market capitalization of $344.56 billion and generates $76.45 billion in revenue each year. The company earns $1.30 billion in net income (profit) each year or $7.30 on an earnings per share basis. Johnson & Johnson employs 134,000 workers across the globe.

The official website for Johnson & Johnson is http://www.jnj.com.

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.